Enter inventor name

Kazuo Nagai

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Erina Co., Inc., Ajinomoto Co., Ltd.. Active years: 2005-2014.

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 75.0

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Toshima-ku, JP (2005)
Kasugai, JP (2010)
Tokyo, JP (2005 - 2014)
Aichi, JP (2014)

Company Filing History:

3 out of 730

Kyowa Hakko Kogyo Co., Ltd.

Meiji Dairiese Corporation

patent

5. 1 out of 834,453

Other

patents

Years Active: 2005-2014

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8822705 - Pharmaceutical composition for preventing and/or treating bone disease, functional food or health food and pharmaceutical preparation comprising thereof as active ingredient (2014-09-02),

2. 8729279 - Agent for promoting osteoblast differentiation, pharmaceutical composition for promoting bone formation, and food for special dietary use containing auraptene analog as active ingredient (2014-05-20),

3. 7803844 - Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients (2010-09-28),

4. 7709537 - Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials (2010-05-04),

5. 7223587 - [object Object] (2007-05-29),

6. 7033802 - Penicillin binding protein gene and process for producing L-glutamic acid (2006-04-25),

7. 6911326 - GlmU polypeptide and DNA encoding the polypeptide (2005-06-28),

8. 6855516 - Gene conferring lysozyme insensitivity to corynebacterium (2005-02-15),

Title: Kazuo Nagai: Innovator in Pharmaceutical Composition

Introduction

Kazuo Nagai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of bone diseases. With a total of 8 patents, his work has garnered attention for its innovative approaches to health and wellness.

Latest Patents

Nagai's latest patents include a pharmaceutical composition designed for preventing and/or treating bone disease. This composition features an arylheptanoid compound that is highly safe and effective. Additionally, he has developed a functional food and health food that incorporate this compound as an active ingredient. Another notable patent involves an agent for promoting osteoblast differentiation, which includes purified auraptene or its coumarin analogs. These inventions highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Kazuo Nagai has worked with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Erina Co., Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Nagai has collaborated with esteemed colleagues, including Masaaki Wachi and Byung-Yoon Cha. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Kazuo Nagai's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of bone disease treatment. His patents reflect a dedication to enhancing health through scientific advancements.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]